Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations
Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high. The post Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations appeared first on BeInCrypto.
Key Takeaways
- Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high.
- The post Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations appeared first on BeInCrypto.
- Read the full article for additional context and details.
Summary generated by IndiCrypto from BeInCrypto. IndiCrypto is a news aggregator and does not provide investment advice. Read the original article for full context.
More in Web3
KuCoin Adds USDT Perpetuals Tied To Stocks And ETFs
KuCoin announced five new USDT-margined perpetual contracts for October 21, including products tracking Goldman Sachs shares and the leveraged MSTU ETF. The contracts offer up to 20x leverage in supported markets.
Malaysia, Thailand join Singapore’s cross-border stablecoin push
BLOOM seeks to cut costs by helping financial institutions coordinate cross-border use of stablecoins and tokenized deposits.
Bitcoin ETFs bleed $635M as October slides back into the red
Thursday’s withdrawals ended a three-day inflow streak and left US spot Bitcoin ETFs with $175 million in net outflows for October.